EANM 2023: The theranostics future is now: Innovative diagnostic application and therapeutic potential of CXCR4
(Only Available in English)
Pentixapharm to hold Symposium at EANM 2023 in Vienna
Monday, September 11, 2023 (13:15 - 14:45), Hall K
Chairperson:
Prof. Ken Herrmann (Clinic of Nuclear Medicine University Hospital Essen)
Program:
CXCR4-directed Theranostics in Hematooncology
Speaker: Prof. Andreas Buck (Clinic of Nuclear Medicine University Hospital Würzburg)
Innovative CXCR4 directed diagnostic application in a common endocrine cause of hypertension
Speaker: Dr. Elisabeth Ng (Monash University Australia)
The Castus Trial: Aim, Design and Current Status
Speaker: Prof. Martin Gotthardt (University Medical Center Radboud University Nijmegen)
Panel Discussion